Document is current
Any future updates will be listed below
-
Authors
Kamat, Kalika
Krishnan, Venkatesh https://orcid.org/0000-0001-9292-4515
Dorigo, Oliver https://orcid.org/0000-0002-1976-5201
-
Funding
Funding for this research was provided by:
This work was supported by the Mary Lake Polan Gynecologic Oncology Endowment for Research (O.D.), the Vivian Scott Fellowship in Gynecologic Oncology (O.D.).
- License Information
-
More Information
Article History
Received: 15 December 2021
Revised: 16 May 2022
Accepted: 7 June 2022
First Online: 24 June 2022
Competing interests
: KK and VK have no competing interests. OD has served on Advisory Boards for Merck, Eisai, PACT, GSK, IMV, Genentech. OD received funding for clinical research from AstraZeneca, IMV, Millenium, Pharmamar, Genentech, Bioeclipse.
: Patient samples were collected under an approved Institutional Review Board (IRB) protocol at Stanford University and the University of Pennsylvania. Informed consent for healthy plasma was obtained by Innovative Research (Novi, MI). This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
